封面
市場調查報告書
商品編碼
1624439

全球穩定同位素標記化合物市場規模(按類型、最終用途、地區、範圍和預測)

Global Stable Isotope Labeled Compounds Market Size By Type (Deuterium, Oxygen-18, Carbon-13, Nitrogen-15), By End-Use (Research Institutes, Pharmaceutical & Biopharmaceutical), By Geographic Scope And Forecast

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

穩定同位素標記化合物的市場規模及預測

穩定同位素標記化合物的市場規模預計在 2021 年價值 2.7823 億美元,到 2030 年將達到 3.8351 億美元,2023 年至 2030 年的複合年增長率為 3.64%。該市場的成長主要歸功於製藥和生物技術領域研究活動的不斷增加。此外,癌症發生率的不斷上升也刺激了使用穩定同位素標記化合物的研究活動。本研究報告對全球穩定同位素標記化合物市場進行了全面的評估。它對關鍵細分市場、趨勢、市場推動因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面的分析。

定義全球穩定同位素標記化合物市場

穩定同位素標記涉及使用非放射性同位素作為示蹤劑來模擬各種化學和生化系統。同位素可透過核磁共振(NMR)和質譜(MS)作為化合物的可識別標籤。常用的穩定同位素包括2H、13C和15N。穩定同位素標記化合物引起了從事代謝介導毒性研究的研究人員的極大興趣。它在大量代謝研究中評估體內代謝的作用變得不容忽視。除了代謝組學研究外,穩定同位素標記化合物越來越多地應用於環境分析、蛋白質組學和醫學診斷研究。

穩定同位素標記化合物的全球市場概況

報告的市場展望部分主要涵蓋基本市場動態、市場推動因素和課題、市場限制和機會。市場推動因素和阻礙因素是內在因素,市場推動因素和課題是外在因素。

該市場的成長主要受到製藥和生物技術領域分析活動增加等因素的推動。此外,癌症發生率的不斷上升也刺激了使用穩定同位素標記化合物的分析活動。此外,由於個人化醫療和藥品領域的分析活動不斷增加,穩定同位素標記化合物市場正在定期增長,預計這將在預測期內促使穩定同位素標記化合物市場健康成長。然而,穩定同位素標記化合物的引入需要較高的資金投入,這是阻礙其成長的最大障礙。

在驗證分析中,我們縮小原始資訊的資料利用範圍以驗證知識,並利用它來匯總全面的分析研究。該報告包含消費者感興趣的市場部分的定量和定性估計。全球穩定同位素標記化合物市場已細分為多個子市場,可以定期提供有關最新趨勢的機密知識。

目錄

第 1 章穩定同位素標記化合物全球市場簡介

    市場概況
  • 研究範圍
  • 先決條件

第 2 章執行摘要

第 3 章:經過驗證的市場研究方法

  • 資料探勘
  • 驗證
  • 主要來源
  • 資料來源列表

第 4 章 穩定同位素標記化合物的全球市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 阻礙因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

第5章 全球穩定同位素標記化合物市場(按類型)

  • 概述
  • 碳-13
  • 氮-15
  • 氧-18

第6章 穩定同位素標記化合物的全球市場(依最終用途劃分)

  • 概述
  • 研究機構
  • 製藥和生物製藥
  • 其他

第7章 全球穩定同位素標記化合物市場(按地區)

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
    亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區
    • 拉丁美洲
    • 中東和非洲

第 8 章穩定同位素標記化合物的全球市場:競爭格局
  • 概述
  • 各公司的市場排名
  • 主要發展策略

第9章 公司簡介

  • Merck KGaA
  • Cambridge Isotope Laboratories, Inc.
  • PerkinElmer Inc.
  • Medical Isotopes, Inc.
  • Omicron Biochemicals, Inc.
  • Taiyo Nippon Sanso Corporation
  • Isosciences
  • Trace Sciences International
  • Alsachim
  • Urenco Stable Isotopes

第 10 章 重大進展

  • 產品發佈/開發
  • 合併和收購
  • 業務擴展
  • 夥伴關係和合作關係

第 11 章附錄

  • 相關研究
Product Code: 24354

Stable Isotope Labeled Compounds Market Size And Forecast

Stable Isotope Labeled Compounds Market size was valued at USD 278.23 Million in 2021 and is projected to reach USD 383.51 Million by 2030 , growing at a CAGR of 3.64% from 2023 to 2030. The growth of this market is majorly driven by factors such as the increase in research activities in the pharmaceutical and biotechnology sector. Also, the rising prevalence of cancer has fuelled research activities using such stable isotope-labeled compounds. The Global Stable Isotope Labeled Compounds Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Stable Isotope Labeled Compounds Market Definition

Stable isotope labeling includes the use of non-radioactive isotopes which can serve as tracers used to model different chemical and biochemical systems. The isotope can act as an identifiable label on that compound through nuclear magnetic resonance (NMR) and mass spectrometry (MS). The Commonly used stable isotopes include 2H, 13C, and 15N. Stable isotope-labeled compounds have generated considerable interest among researchers engaged in metabolism-mediated toxicity studies. Their role has risen to insignificance in the assessment of in vivo metabolism in a vast range of metabolic research. Apart from metabolomics studies, stable isotope-labeled compounds are being increasingly used in environmental analysis, proteomics, and medical diagnostic research.

Global Stable Isotope Labeled Compounds Market Overview

The report's market outlook section primarily encompasses essential market dynamics, drivers, restraints, opportunities, and challenges the trade faces. Drivers and restraints are intrinsic factors, whereas opportunities and challenges are extrinsic factors of the market.

The growth of this market is majorly driven by factors like the rise in analysis activities within the pharmaceutical and biotechnology sector. Also, the rising prevalence of cancer has fuelled analysis activities using such stable isotope-labeled compounds. Moreover, the increase at intervals in the Stable Isotope Labeled Compounds Market due to the rise in analysis activity, significantly at intervals in the area of customized medicine and medicines, presents a superb chance for the Stable Isotope Labeled Compounds Market to grow healthy over the forecast amount. However, implementing stable isotope-labeled compounds needs high capital investments, which is the most critical barrier to plug growth.

Verified analysis narrows down their data exploitation of primary sources to validate the knowledge and use it in the aggregation of a full-fledged analysis study. The report contains a quantitative and qualitative estimation of market parts that interest the consumer. The "Global Stable Isotope Labeled Compounds Market" is split into sub-segments that can provide classified knowledge regarding the most recent trends at intervals.

Global Stable Isotope Labeled Compounds Market: Segmentation Analysis

The Global Stable Isotope Labeled Compounds Market is Segmented on the basis of Type, End-Use, and Geography.

Stable Isotope Labeled Compounds Market, By Type

  • Deuterium
  • Oxygen-18
  • Carbon-13
  • Nitrogen-15

Based on Type, the market is segmented into Deuterium, Oxygen-18, Carbon-13, and Nitrogen-15. Deuterium accounted for the largest market share in 2019 followed by Oxygen-18. Deuterium-labeled compounds have been utilized efficiently by toxicologists and drug metabolism scientists to gain an understanding of drug disposition and the potential performance of these compounds in the target organ toxicities.

Stable Isotope Labeled Compounds Market, By End-Use

  • Research Institutes
  • Pharmaceutical & Biopharmaceutical
  • Others

Based on End-Use, the market is segmented into Research Institutes, Pharmaceutical & Biopharmaceutical, and Others. Research Institutes accounted for the largest market share in 2019. Government research institutes, medical research institutes, and academic research institutes employ stable isotope-labeled compounds for performing metabolomics and proteomics research studies.

Stable Isotope Labeled Compounds Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Regional Analysis, the Global Stable Isotope Labeled Compounds Market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is the major contributor to the Stable Isotope Labeled Compounds Market partly due to the prevalence of cancer treatment and its research as well as the rising older population in the Americas.

Key Players

  • The "Global Stable Isotope Labeled Compounds Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
  • Merck KGaA, Cambridge Isotope Laboratories, Inc., PerkinElmer Inc., Medical Isotopes, Inc., Omicron Biochemicals, Inc., Taiyo Nippon Sanso Corporation, Isosciences, Trace Sciences International, Alsachim, Urenco Stable Isotopes.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with their product benchmark and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • In July 2021, Cambridge Isotope Laboratories, Inc. (CIL), part of the Otsuka Group and the world's leading producer of stable isotopes and stable isotope-labeled compounds, has launched the first commercially available 12C-enriched methane-grade gas for quantum applications.
  • In July 2021, Bruker has entered into a partnership with Massachusetts-based Cambridge Isotope Laboratories (CIL), formalizing a long-term relationship between the two companies and further extending Bruker's capabilities to deliver end-to-end service solutions to its installed customer base in nuclear magnetic resonance (NMR) spectroscopy under the LabScape(R) brand.
  • In June 2020, Creative Proteomics, the main provider in proteomics and metabolomics services, delivered a few proteomics services to scientists. The assistance ranges incorporate four: iTRAQ naming help, name-free quantitation service, SILAC mass spectrometry service, and TMT proteomics service.
  • In June 2020, Cambridge Isotope Laboratories, (CIL) the largest manufacture and global supplier of stable isotopes and stable isotope-labeled compounds, collaborated with Alsachim to provide antiviral drug standards to researchers and clinicians exclusively in the Americas. These products are available through CIL in convenient packaging sizes and are adept for use as internal standards in therapeutic monitoring and quantitative analysis.
  • In December 2020, Cambridge Isotope Laboratories, Inc. (CIL), the world leader in stable isotope chemistry and the separation of carbon-13 (13C), recently began a significant capacity optimization of one of the production cascades at the 13C separation facility in Xenia, Ohio. This optimization, which began this past summer and is scheduled for completion in the summer of 2021, will increase the cascade's 13C production by 10%.
  • Merger & Acquisitions
  • In April 2018, TAIYO NIPPON SANSO CORPORATION totally acquired SAIL advances Inc., where it's valuable in assembling and conveying stable isotope-marked amino acids that are material in biotechnology-related businesses and the medication industry.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Carbon-13
  • 5.3 Nitrogen-15
  • 5.4 Deuterium
  • 5.5 Oxygen-18

6 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE

  • 6.1 Overview
  • 6.2 Research Institutes
  • 6.3 Pharmaceutical & Biopharmaceutical
  • 6.4 Others

7 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East & Africa

8 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Merck KGaA
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Cambridge Isotope Laboratories, Inc.
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 PerkinElmer Inc.
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Medical Isotopes, Inc.
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Omicron Biochemicals, Inc.
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Taiyo Nippon Sanso Corporation
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Isosciences
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Trace Sciences International
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Alsachim
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 Urenco Stable Isotopes
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

  • 10.1 Product Launches/Developments
  • 10.2 Mergers and Acquisitions
  • 10.3 Business Expansions
  • 10.4 Partnerships and Collaborations

11 Appendix

  • 11.1 Related Research

LIST OF TABLES

  • TABLE 1 PRICING ANALYSIS
  • TABLE 2 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 3 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 4 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY GEOGRAPHY, 2018 - 2027 (USD MILLION)
  • TABLE 5 NORTH AMERICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY COUNTRY, 2018 - 2027 (USD MILLION)
  • TABLE 6 NORTH AMERICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 7 NORTH AMERICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 8 U.S. STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 9 U.S. STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 10 CANADA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 11 CANADA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 12 EUROPE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY COUNTRY, 2018 - 2027 (USD MILLION)
  • TABLE 13 EUROPE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 14 EUROPE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 15 GERMANY STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 16 GERMANY STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 17 ITALY STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 18 ITALY STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 19 BENELUX STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 20 BENELUX STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 21 UK STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 22 UK STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 23 RUSSIA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 24 RUSSIA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 25 SPAIN STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 26 SPAIN STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 27 FRANCE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 28 FRANCE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 29 REST OF EUROPE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 30 REST OF EUROPE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 31 ASIA PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY COUNTRY, 2018 - 2027 (USD MILLION)
  • TABLE 32 ASIA PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 33 ASIA PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 34 CHINA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 35 CHINA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 36 JAPAN STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 37 JAPAN STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 38 SOUTH KOREA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 39 SOUTH KOREA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 40 REST OF ASIA-PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 41 REST OF ASIA-PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 42 MIDDLE EAST AND AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY COUNTRY, 2018 - 2027 (USD MILLION)
  • TABLE 43 MIDDLE EAST AND AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 44 MIDDLE EAST AND AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 45 GCC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 46 GCC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 47 TURKEY STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 48 TURKEY STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 49 SOUTH AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 50 SOUTH AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 51 NORTH AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 52 NORTH AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 53 LATIN AMERICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY COUNTRY, 2018 - 2027 (USD MILLION)
  • TABLE 54 LATIN AMERICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 55 LATIN AMERICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 56 BRAZIL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 57 BRAZIL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 58 MEXICO STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 59 MEXICO STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 60 MERCK KGAA: PRODUCT BENCHMARKING
  • TABLE 61 CAMBRIDGE ISOTOPE LABORATORIES, INC.: PRODUCT BENCHMARKING
  • TABLE 62 PERKINELMER INC.: PRODUCT BENCHMARKING
  • TABLE 63 MEDICAL ISOTOPES, INC.: PRODUCT BENCHMARKING
  • TABLE 64 OMICRON BIOCHEMICALS, INC.: PRODUCT BENCHMARKING
  • TABLE 65 TAIYO NIPPON SANSO CORPORATION: PRODUCT BENCHMARKING
  • TABLE 66 ISOSCIENCES: PRODUCT BENCHMARKING
  • TABLE 67 TRACE SCIENCES INTERNATIONAL: PRODUCT BENCHMARKING
  • TABLE 68 ALSACHIM: PRODUCT BENCHMARKING
  • TABLE 69 URENCO STABLE ISOTOPES: PRODUCT BENCHMARKING

LIST OF FIGURES

  • FIGURE 1 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SEGMENTATION
  • FIGURE 2 RESEARCH TIMELINES
  • FIGURE 3 DATA TRIANGULATION
  • FIGURE 4 MARKET RESEARCH FLOW
  • FIGURE 5 DATA SOURCES
  • FIGURE 6 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET OVERVIEW
  • FIGURE 7 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET GEOGRAPHICAL ANALYSIS, 2020- 2027
  • FIGURE 8 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY PRODUCT TYPE, (USD MILLION)
  • FIGURE 9 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY APPLICATION (USD MILLION)
  • FIGURE 10 FUTURE MARKET OPPORTUNITIES
  • FIGURE 11 NORTH AMERICA DOMINATED THE MARKET IN 2019
  • FIGURE 12 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET OUTLOOK
  • FIGURE 13 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE
  • FIGURE 14 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE
  • FIGURE 15 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY GEOGRAPHY, 2018 - 2027 (USD MILLION)
  • FIGURE 16 NORTH AMERICA MARKET SNAPSHOT
  • FIGURE 17 EUROPE MARKET SNAPSHOT
  • FIGURE 18 ASIA PACIFIC MARKET SNAPSHOT
  • FIGURE 19 MIDDLE EAST AND AFRICA MARKET SNAPSHOT
  • FIGURE 20 LATIN AMERICA MARKET SNAPSHOT
  • FIGURE 21 MERCK KGAA: COMPANY INSIGHT
  • FIGURE 22 MERCK KGAA: SEGMENT BREAKDOWN
  • FIGURE 23 MERCK KGAA: SWOT ANALYSIS
  • FIGURE 24 CAMBRIDGE ISOTOPE LABORATORIES, INC.: COMPANY INSIGHT
  • FIGURE 25 CAMBRIDGE ISOTOPE LABORATORIES, INC.: SWOT ANALYSIS
  • FIGURE 26 PERKINELMER INC.: COMPANY INSIGHT
  • FIGURE 27 PERKINELMER INC.: SEGMENT BREAKDOWN
  • FIGURE 28 PERKINELMER INC.: SWOT ANALYSIS
  • FIGURE 29 MEDICAL ISOTOPES, INC.: COMPANY INSIGHT
  • FIGURE 30 OMICRON BIOCHEMICALS, INC.: COMPANY INSIGHT
  • FIGURE 31 TAIYO NIPPON SANSO CORPORATION: COMPANY INSIGHT
  • FIGURE 32 TAIYO NIPPON SANSO CORPORATION: SEGMENT BREAKDOWN
  • FIGURE 33 ISOSCIENCES: COMPANY INSIGHT
  • FIGURE 34 TRACE SCIENCES INTERNATIONAL: COMPANY INSIGHT
  • FIGURE 35 ALSACHIM: COMPANY INSIGHT
  • FIGURE 36 URENCO STABLE ISOTOPES: COMPANY INSIGHT